1Ishihara T,Yokota N,Hisanaqa S,et al. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure [J]. Clin Nephrol, 1999,52 (2):119 -123.
2Cases A, Esforzado N, Vera M, et al. Increased adrenomedullin levels in hypertensive patients on maintenance hemodialysis [J]. Nefroloqia, 2000,20(5) : 424 - 430.
3Cases A, Esforzado N, Lario S, et al. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension[J]. Kidney Int,2000,57(2) : 664 - 670.
5Kitamura K, kanguwa M, Kawamato M, et al. Adrenomedullin:h novel hypotensive peptide isolated from human pheochromocytoma[J]. Biochem Biopohys Res Commun, 1993, 192: 553- 560.
6Vanholder R, Smet RD, Glorieux, et al. Review on uremic toxins:Classification, concentration, and interindividual variability[J].Kidney International, 2003,63:1934-1943.
7Ishimitsu T, Nishikimi T, Saito Y, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure[J]. J Clin Invest, 1994,94:2158-2161.
8Nishikimi T, Saito Y, Kitamura K, et al. Increased plasma levels of adrenomedullin in patients with heart failure [J].J Am Coll Cardiol, 1995; 26:1424-1431.
9Ishihara T, Yokota N, Hisanaga S. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failare[J].Clin Nephrol, 1999,52:119-23.
10ParkJB, Charbonneau F, Schiffrin EL. Correlation of endothelial faction in large and small arteries in human essential hypertension[J].Hypertens, 2001,19:415-420.
